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The present study compared the effects of diets formulated with reduced fishmeal 26 
(FM) content and either 100% fish oil (FO) or 100% of a vegetable oil (VO) blend in 27 
post-smolts of three family groups of Atlantic salmon. Two groups were selected as 28 
being either “Lean” or “Fat” based on estimated breeding values (EBV) for flesh 29 
adiposity of their parents derived from a breeding programme, while the third group 30 
(CAL) was a mix of non-pedigreed commercial families unrelated to the two groups 31 
above. The VO blend comprised rapeseed, palm and a new product, Camelina oil in 32 
a ratio of 5/3/2, and diets were fed to duplicate pens of each salmon group. After an 33 
ongrowing period of 55 weeks, to reach a mean weight of 3kg, the fish from all 34 
treatments were switched to a decontaminated FO for a further 24 weeks to follow 35 
restoration of long-chain n-3 polyunsaturated fatty acids (LC-PUFA) in the fish 36 
previously fed VO. Final weights were significantly affected by family group and 37 
there was also an interaction between diet and group with Fat and Lean FO fish being 38 
larger than the same fish fed VO. Specific growth rate (SGR) was highest in CAL 39 
fish (1.01), feed conversion ratio (FCR) was highest in the Lean fish but there were 40 
no significant effects on thermal growth coefficient (TGC). Condition Factor (CF) 41 
was lowest in CAL fish while the hepato-somatic index (HSI) was highest in Lean 42 
fish and viscero-somatic index (VSI) highest in Fat fish. Flesh and viscera lipid 43 
content was affected by both family group and diet with a significant interaction 44 
between the two. Flesh lipid in fish fed FO was in the order Fat > CAL > Lean 45 
although this order was Fat = Lean > CAL when fed VO. Flesh fatty acid 46 
compositions were affected mainly by diet although some minor fatty acids were also 47 
 3 
influenced by group. Fish fed VO had n-3 LC-PUFA reduced by ~65% compared to 48 
fish fed FO but this could be restored by a 16 week FO finishing diet phase. The 49 
differences observed in lipid and fatty acid deposition suggested that genetics 50 
affected lipid deposition and metabolism and that breeding programmes could select 51 
for fish that retained more n-3 LC-PUFA in their flesh, particularly when fed diets 52 
low in these fatty acids.  53 
 54 
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1. Introduction 71 
Worldwide demand for seafood continues to expand while traditional fisheries are 72 
at best stable or in decline, and recent evidence suggests that aquaculture production 73 
now provides half of all seafood (FAO, 2009). In recent times global production of 74 
Atlantic salmon increased from ~0.9 million metric tonnes (MT) in 2000 to 1.5m MT 75 
in 2006 and as such is the largest production of a marine fish species globally (FAO, 76 
2008). As with most carnivorous fish, salmon has traditionally been cultured using 77 
diets rich in fishmeal (FM) and fish oil (FO), which has placed excessive demand on 78 
these raw materials, resulting in increased prices and concerns about ethical 79 
sustainability. Production of FO globally has ranged from 1.0m to 1.5m metric tonnes 80 
between 1980 and 2006 and there is no likelihood of this increasing (Tacon and 81 
Metian, 2008). Recent estimates of FO use by aquaculture suggested 87% of global 82 
production is currently utilised with salmonid culture being the major user at 66.4% of 83 
total FO production (Tacon et al., 2006). Tacon et al., 2006 suggested that aquaculture 84 
would use 88% of FO production up to 2012 while an earlier study suggested that 98% 85 
could be consumed by 2010 (Pike & Barlow, 2003). All of these predictions could be 86 
eclipsed if a severe El Nino event occurs in the next few years, as has been widely 87 
predicted. In summary, the need to establish alternatives to FM and FO has never been 88 
more urgent if aquaculture production is to increase and seafood supply and nutritional 89 
quality is to be maintained. 90 
Several studies conducted recently have shown that terrestrial vegetable oils 91 
(VO), either singly or as blends, can replace some or all of the added FO in salmonid 92 
feeds largely without any compromise in growth or fish health and condition (Bell et 93 
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al., 2001, 2004; Torstensen et al., 2000, 2004a, 2005; Richard et al., 2006; Karalazos 94 
et al., 2007). However, replacement of FO, rich in the n-3 LC-PUFA, eicosapentaenoic 95 
(20:5n-3; EPA) and docosahexaenoic acids (22:6n-3: DHA), with VOs devoid of n-3 96 
LC-PUFA but rich in α-linolenic acid (18:3n-3) and especially linoleic acid (18:2n-6), 97 
can significantly reduce the flesh n-3 LC-PUFA concentration by more than 50% if 98 
total FO replacement is implemented (Bell et al., 2004; Torstensen et al., 2005; 99 
Richard et al., 2006). While salmon grown on diets rich in VO have reduced n-3 LC-100 
PUFA, such products are still rich in n-3 LC-PUFA compared to most other fish 101 
species (Bell and Tocher, 2009). However, given the well established efficacy of n-3 102 
LC-PUFA in preventing and attenuating a range of inflammatory disorders, including 103 
cardiovascular disease, immune dysfunction and neurological conditions, it is vitally 104 
important to maintain flesh n-3 LC-PUFA in salmon at levels close to those found in 105 
salmon fed largely on FO (Young and Conquer, 2005; Ruxton et al., 2005; Bell, 106 
2008). Finishing diets rich in marine FO have been used to restore n-3 LC-PUFA 107 
levels in market size salmon that had previously been fed high levels of VO. Feeding 108 
FO finishing diets to fish previously fed VOs, for periods of 16-24 weeks, have 109 
successfully restored flesh levels n-3 LC-PUFA to 80-100% of their concentrations in 110 
FO-fed fish (Bell et al., 2004; Torstensen et al., 2005). 111 
As described above, there is an extensive literature on the replacement of FO with 112 
both single and blended VOs in a range of fish species and there is a similar body of 113 
literature on the replacement of FM with plant proteins. In salmonids, partial or total 114 
replacement of FM with plant proteins has been demonstrated by a number of authors, 115 
although in some cases growth reduction was observed, which may have been due to 116 
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the presence of anti-nutritional factors that impacted on feed intake and gut function 117 
(Kaushik et al., 1995; de Francesco et al., 2004; Espe et al., 2006). Interestingly, lipid 118 
retention was increased in rainbow trout but decreased in Atlantic salmon when fed 119 
high levels of plant protein (Kaushik et al., 2004; Espe et al., 2006). While the current 120 
project focused more on the complete replacement of FO with VO on different salmon 121 
family groups, the levels of FM and plant protein used were lower and higher, 122 
respectively, than in commercial salmon diets used in 2006. Hence, a secondary aim 123 
was to develop and test feed formulations that significantly reduced dependence on 124 
marine resources and result in more sustainable aquafeed products. 125 
The proximate composition of fish flesh, and especially the lipid content, has an 126 
impact on the sensory quality of the flesh that also impacts on consumer preferences 127 
that may vary between different geographic regions and cultures. It is therefore 128 
important for the aquaculture industry to produce fish that use the dietary nutrients to 129 
promote muscle growth over adipose growth as well as meeting consumer perceptions 130 
in fulfilling optimal quality parameters. Thus, the ability to develop breeding 131 
programmes in farmed fish that exploit desirable phenotypic and genotypic traits that 132 
influence lipid deposition or adiposity has resulted in recent research activity (Neira et 133 
al., 2004; Quillet et al., 2005; Tobin et al., 2007). There is also evidence that lipostatic 134 
regulation can be influenced by dietary lipid and protein content in fat and lean strains 135 
of fish and chickens (Bourneuf et al., 2006; Tobin et al., 2007; Kause et al., 2009). 136 
Evidence suggests that retention of n-3 LC-PUFA subject to genetic control in poultry 137 
(Mennicken et al., 2005). 138 
 7 
The primary aim of this study was to grow Atlantic salmon smolts, for the whole 139 
marine production phase, on diets with reduced FM diets and that contained either 140 
100% of added oil as FO or a blend of VOs. Each of these two diets was fed to either 141 
“Lean” or “Fat” salmon families as well as a commercial strain used in previous 142 
studies on FO replacement (Bell et al., 2004; Torstensen et al., 2005). Flesh fatty acid 143 
compositions were determined at final sampling for the ongrowing phase. Thereafter, 144 
all fish were placed on a FO diet, containing a decontaminated FO for the finishing 145 
diet phase, and flesh fatty acid concentrations measured after 8, 16 and 24 weeks on 146 
the FO finishing diet.  147 
 148 
2. Materials and Methods 149 
2.1 Fish Populations 150 
Three genetically characterised and contrasting groups of farmed Atlantic salmon 151 
post-smolts were provided for the feed trials. Two groups comprised full-sib families 152 
selected from the Landcatch Natural Selection Ltd breeding program (Argyll, 153 
Scotland) based on estimated breeding values (EBVs) of their parents for high or low 154 
flesh adiposity. The parental EBVs were derived from Torry Fatmeter (Distell 155 
Industries, West Lothian, UK) lipid assessments (recorded from microwave 156 
reflectance of fat as a percent of body weight) obtained on live and harvested sibs of 157 
those parents. These assessments have a heritability (proportion of observed variation 158 
due to family differences) ranging from 0.17 to 0.39 in this dataset. Four unrelated 159 
full-sib families were then created from the selected parents at the November 2004 160 
stripping season, two families from the extreme lower end of the EBV distribution for 161 
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Torry fat meter assessed lipid content (“Lean”) and two families from the extreme 162 
upper end of the distribution (“Fat”). The average EBV for the lipid content as 163 
determined by Torry fat meter of the two Fat families was 2.00 percentage units higher 164 
than that of the two selected Lean families, representing a standardised selection 165 
differential of 2.33 standard deviations (sds). The corresponding standardised selection 166 
differential of the two Fat families for weight EBV at harvest was 0.62 sds ie the Lean 167 
families being genetically slightly heavier than the Fat families.  A third group was of 168 
non-pedigreed mixed families derived from the Caledonian 20 strain (CAL; Marine 169 
Harvest Scotland Ltd.), which had been used in previous replacement trials (Bell et al., 170 
2004; Torstensen et al., 2005).  171 
Two thousand smolts of each of the three groups were stocked into 12 x 5m3 net 172 
pens at the Ardnish Fish Trials Unit (Marine Harvest Scotland, Lochailort, PH38 4LZ, 173 
Highland; 500 fish/pen) and the initial mean weights were 52, 88 and 85g for the 174 
CAL, Fat and Lean fish, respectively. Thus, there were 4 pens for each of the 3 groups 175 
with each of the two diets being feed to duplicate pens for each group. The 176 
temperature over the experimental period (May 2006 to December 2007) ranged from 177 
5.5 to 17.0oC with a mean temperature of 11.5 ± 2.9oC. 178 
2.2 Experimental diets 179 
The fish were fed one of two experimental diets, prepared by Skretting ARC 180 
(Stavanger, Norway) in 3 different pellet sizes (3, 6 and 9 mm) for a period of 55 181 
weeks until the fish reached a weight of ~3 kg. The diets were formulated to fully 182 
satisfy the nutritional requirements of salmonid fish (NRC, 1993). Duplicate pens of 183 
each of the 3 genetic groups were fed a similar basal diet containing either 100% 184 
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Northern FO or a VO blend comprising rapeseed, palm and Camelina oils in a ratio of 185 
5:3:2. The oil of the plant Camelina sativa is a new addition to aquaculture feeds 186 
although it has been used since Neolithic times as a lamp oil and also in cosmetics. It 187 
is low in saturated fatty acids and contains 18:3n-3 and 18:2n-6 PUFA in a ratio of 188 
~2:1. It is unusual in being rich in the monoene fatty acid, 20:1n-9, representing 189 
around 15% of the fatty acids and is more usually found in marine FO where it is a 190 
preferred source of dietary energy. Its seeds contain more than 40% oil and it can be 191 
grown in arid conditions not tolerated by other oilseeds and requires minimal use of 192 
fertilisers, herbicides or pesticides (INFORM, 2007). The diets contained 25-32% FM 193 
and 40-45% plant meals. After sampling at 55 weeks, 60 fish/pen for each group, 194 
weighing between 2.0 and 3.5 kg, were placed in a single pen and the fish that had 195 
previously been fed the VO diet were marked by adipose fin clipping. Thus, the 196 
original 12 pens were reduced to 3 and these pens were fed a finishing diet, having the 197 
same basal formulation as the 9 mm ongrowing diet but coated with a decontaminated 198 
FO (sand eel/sprat oil, 9:1v/v; Triple Nine Protein, Denmark), for a further 24 weeks. 199 
The diet formulations and proximate compositions of the 6 and 9 mm ongrowing feeds 200 
are shown in Table 1. Fatty acid compositions of the 9 mm FO and VO diets and the 9 201 
mm finishing diet are shown in Table 2. Diets were supplied by automatic feeders 202 
controlled by an automated feed sensor system (ArvoTec, Sterner AquaTech UK, 203 
Scotland). Feed use and mortalities were recorded and removed daily.  204 
2.2 Sampling procedures 205 
At 55 weeks, 25 fish were sampled per pen, killed by a blow to the head following 206 
anaesthesia using MS222, and length, weight, viscera and liver weight recorded. From 207 
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ten fish/pen steaks from the Norwegian Quality Cut region (NQCs; a steak cut 208 
between the end of the dorsal fin to the vent) were collected and immediately frozen 209 
on dry ice and transported to the laboratory where they were stored for a short time at -210 
20oC before being processed. The steaks were thawed, skinned and deboned and then 211 
2 flesh pools per pen, each comprising 5 fish/pool, were prepared for flesh fatty acid 212 
and proximate analyses. Samples of viscera and liver were prepared similarly. At the 213 
finishing diet sampling points, 24 fish per pen, 12 each from fish previously fed the 214 
FO or VO diets, were sampled after 16 and 24 weeks on the finishing diet. Four half 215 
NQCs were pooled to provide 3 replicates for each dietary treatment and genetic 216 
group. Samples were stored on dry ice for transport and stored and processed as 217 
described above.  218 
 219 
2.3 Proximate compositions of diets and tissues 220 
Moisture was determined by thermal drying to constant weight at 110oC for 24h. 221 
Crude protein content was determined by Kjeldahl analysis (nitrogen x 6.25; Kjeltec 222 
Autoanalyser, Tecator, Hoganas, Sweden). Crude fat was determined in diets 223 
following acid hydrolysis using a Soxtec System 1047 hydrolysing unit (Tecator 224 
Application note 92/87) followed by exhaustive Soxhlet extraction using petroleum 225 
ether (40-60oC boiling point) on a Soxtec System HT6 (Tecator application note 226 
67/83). The crude fat in flesh, viscera and liver homogenates was determined by the 227 
above procedure but without acid hydrolysis. The ash content was determined by dry 228 
ashing in a porcelain crucible in a muffle furnace at 600oC overnight. All methods are 229 
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based on those described in the Association of Official Analytical Chemists (AOAC) 230 
(2000) and modified as described in Bell et al. (2001).  231 
 232 
2.4 Lipid extraction and fatty acid analysis 233 
Total lipids were extracted from 1-2 g of pooled muscle or liver by homogenising 234 
in 20 volumes of chloroform/methanol (2:1 v/v) in an Ultra Turrax tissue disrupter 235 
(Fisher Scientific, Loughborough, UK). Total lipids were prepared according to the 236 
method of Folch et al. (1957) and non-lipid impurities were removed by washing with 237 
0.88% (w/v) KCl. The weight of lipids was determined gravimetrically after 238 
evaporation of the solvent and overnight desiccation under vacuum. Fatty acid methyl 239 
esters (FAME) were prepared by acid-catalysed transesterification of total lipids 240 
according to the method of Christie (2003). Extraction and purification of FAME was 241 
performed as described by Ghioni et al. (1996). FAME were separated and quantified 242 
by gas-liquid chromatography using a Thermo Fisher Trace GC 2000 (Thermo Fisher, 243 
Hemel Hempstead, UK) equipped with a fused silica capillary column (ZB wax, 30 m 244 
x 0.32 mm i.d.; Phenomenex, Macclesfield, UK) with hydrogen as carrier gas and 245 
using on-column injection. The temperature gradient was from 50 to 150oC at 246 
40oC/min and then to 195oC at 1.5oC/min and finally to 220oC at 2oC/min. Individual 247 
methyl esters were identified by comparison with known standards and by reference to 248 
published data (Ackman, 1980). Data were collected and processed using the 249 
Chromcard for Windows (version 2.00) computer package (Thermoquest Italia S.p.A., 250 
Milan, Italy).  251 
2.5 Calculations 252 
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The following formulae were applied to the data: 253 
Specific growth rate (SGR) was calculated as % daily growth increase: 254 
SGR = (ln W1 – ln W0) x (days of trial
-1) x 100 255 
Where W0  and W1 are the initial and final body weights, respectively. 256 
Feed conversion ratio (FCR) was calculated as the amount of dry diet consumed 257 
and the total biomass gain: 258 
FCR = (feed intake, kg) x (wet weight gain, kg)-1 259 
Thermal Growth Coefficient (TGC) = [(W1)
1/3 – (W0)
1/3] x (days x Co)-1 x 1000 260 
Condition factor (CF) = W (g) x (fork length, cm)-3 x 100 261 
Hepato-somatic index, HSI% = 100 x (liver weight, g) x W  (g)-1 262 
Viscero-somatic index, VSI% = 100 x (viscera weight, g) x W (g)-1 263 
2.6 Statistical analysis 264 
The significance of differences (P < 0.05) were determined by one-way (Figure 1 265 
data) or two-way ANOVA (all other data sets). The latter was used to determine the 266 
effects of diet, fish group and their interactions on growth parameters and lipid 267 
compositions. In data analysed by one-way ANOVA differences between means were 268 
determined by Tukey’s test. Data identified as non-homogeneous (Bartlett’s test) were 269 
subjected to log or arc sin transformation before applying ANOVA. Statistical 270 
analyses were performed using a Graphpad Prism™ (version 4.0) statistical package 271 
(Graphpad Software, San Diego, CA). 272 
 273 
3. Results 274 
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At the end of the 55-week feeding trial, there were no differences observed for 275 
final length or TGC but there was a significant effect of fish group on both SGR and 276 
FCR (Table 3). SGRs ranged from 0.89 and 1.01 with the highest values in CAL fish 277 
and lower values in the Lean and Fat fish. FCRs ranged from 1.06 to 1.39 with 278 
lowest values in CAL fish and the highest values in the Lean VO fish. SGR, TGC 279 
and FCR values are within normal ranges for cage-cultured salmon. There was a 280 
significant effect of group, and interaction between group and diet on the final fish 281 
weights, with lowest weights in the CAL FO and VO fish and the Fat VO fish, while 282 
the largest fish were the Lean and Fat FO fish. However, the lower final weight in 283 
the CAL fish may be due to them being only 52g at the start of the trial compared to 284 
the Lean and Fat groups which were ~87g (Table 3). The values for CF, HSI, and 285 
VSI were influenced by fish group. CF was highest in Fat fish and lowest in CAL 286 
fish while HSI was highest in Lean fish compared with Fat and CAL fish and VSI 287 
was highest in Fat fish compared to the Lean and CAL fish (Table 3).  288 
The flesh lipid content was significantly affected by fish group and there was also 289 
a significant interaction between group and diet (Table 4). The Lean and Fat families 290 
were selected on the basis of their estimated genetic potential for muscle lipid 291 
content and the data from the fish fed FO supports this position with the order of 292 
lipid content being Fat > CAL > Lean (Table 4). However, when the fish were fed 293 
100% VO this order was changed to Fat = Lean > CAL. The pattern of visceral lipid 294 
content was also significantly affected by group and there was a significant 295 
interaction between group and diet (Table 4).  The highest level of visceral fat 296 
deposition was seen in the Fat FO fish followed by the Fat VO and Lean FO and VO 297 
 14 
fish with lowest fat in the CAL fish. Liver lipid content was significantly influenced 298 
by both group and diet and there was a significant interaction between the factors 299 
(Table 4). Liver lipid content was highest in Fat VO fish (4.8%) and lowest in CAL 300 
FO fish (3.2%). In both the Fat VO and CAL VO fish the lipid content was higher 301 
than in the same fish fed FO although this was not the case for the Lean FO and VO 302 
fish. Flesh protein content was also significantly affected by both diet and group 303 
(Table 4). The highest flesh protein was seen in the Lean VO fish and the lowest in 304 
the Fat FO fish.  305 
All flesh fatty acids were significantly affected by diet with the exception of the 306 
minor fatty acid 22:1n-9, and a number of fatty acids were also significantly affected 307 
by fish group including 16:0, 18:0, 20:2n-6 and 18:4n-3, but only 20:2n-6 showed an 308 
interaction between factors (Table 5). As would be expected, the flesh fatty acids 309 
reflected the changes in dietary fatty acids. The main effects observed were a slight 310 
reduction in total saturated fatty acids, from 23 to 18%, which was balanced by an 311 
increase in monounsaturates from 44 to 50% in fish fed VO. In the n-6 fatty acids, 312 
18:2n-6 was increased by ~2-fold as was 20:2n-6, 20:3n-6 and total n-6, in the fish 313 
fed VO, while ARA was reduced by 50% (Table 5). In the n-3 PUFA, 18:3n-3 was 314 
increased almost 3-fold while all other n-3 fatty acids were reduced in fish fed VO. 315 
Flesh EPA and DHA were each reduced by 70% in the Lean fish and by 65% in the 316 
CAL fish.  317 
After 55 weeks, fish from all treatments were placed on a FO finishing diet and 318 
flesh DHA + EPA (%) values were measured at 0, 16 and 24 weeks after switching 319 
to this diet (Fig. 1). After 16 weeks on the FO finishing diet, DHA + EPA values 320 
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were 25% lower in the CAL and Fat fish previously fed VO but only 11% lower in 321 
the Lean VO fish, compared to fish fed FO throughout (Fig. 1).  After 24 weeks on 322 
the FO finishing diet, DHA + EPA values were still 14% lower in the CAL and Fat 323 
fish previously fed VO and 11% lower in the Lean fish fed VO, compared to fish fed 324 
FO throughout. For each fish group and diet the flesh content of EPA + DHA was 325 
calculated as g /140g flesh at 0, 16 and 24 weeks on the FO finishing diet (Fig. 2). 326 
The total EPA + DHA available to consumers, in each experimental group, was 327 
compared to the weekly intake values for DHA + EPA recommended by the 328 
International Society for the Study of Fatty Acids and Lipids (ISSFAL, 2004). After 329 
55 weeks, a 140g portion of the FO-fed fish would provide 49-53% of the ISSFAL 330 
recommended weekly intake while the VO-fed fish would provide 13-17% of this 331 
value. After 16 weeks on the finishing diet a 140g portion of FO-fed flesh would 332 
provide 63-76% of the recommended weekly intake while the VO-fed fish would 333 
provide 46-61% of this value. After 24 weeks on the finishing diet a 140g portion of 334 
FO-fed flesh would provide 71-83% of the weekly intake while VO-fed fish would 335 
provide 63-78% of the recommended value. 336 
4. Discussion 337 
In the present trial the basal diet contained 25% FM compared to commercial 338 
salmon feeds in 2006 that contained 35-40% FM. Plant proteins were included at 339 
~45% of the formulation with the major components being maize and wheat glutens, 340 
and soy meal and concentrate. These plant proteins have provided good growth in 341 
previous FM replacement studies (Kaushik et al., 2004; Espe et al., 2006). The oil 342 
component of the base diet was either 100% northern FO or a blend of VOs 343 
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(rapeseed/palm/Camelina; (5/3/2 by weight). The oil from Camelina sativa is low in 344 
saturates (~10%) and has a ratio of 18:3n-3/18:2n-6 of ~2:1. In the total MUFA, 345 
(~30%) this oil is unusual in that the major fatty acid is 20:1n-9 (~16%), a fatty acid 346 
normally abundant in high latitude FO and highly favoured for energy production by 347 
the β-oxidation pathway (Henderson, 1996; Stubhaug et al., 2007). Camelina is 348 
potentially price competitive with the major oilseeds and can grow in arid conditions 349 
not tolerated by other oilseeds and requires minimal application of fertiliser and plant 350 
protection products (INFORM, 2007). 351 
Numerous studies have been conducted in salmon, using partial or complete 352 
replacement of FO with VO, that have shown no reduction in growth or feed 353 
conversion (Bell et al., 2003, 2004; Torstensen et al., 2000, 2004a; Bransden et al., 354 
2003; Karalazos et al., 2007) or in some cases improved growth and feed conversion 355 
at low water temperatures (Torstensen et al., 2005; Karalazos et al., 2007). Despite 356 
the reduction of FM in the present study, compared to the studies above (FM = 31-357 
74%), growth rates were within expected values for cage-cultured salmon over the 358 
whole sea water production with SGR, TGC and FCRs values of ~0.94, 3.54 and 359 
1.17, respectively (Bell et al., 2004; Torstensen et al., 2004a, 2005). In a recent study 360 
in salmon, FM and FO were both replaced sequentially to provide four diets 361 
containing FM/FO inclusion at 62/25, 12/16, 30/6.5 and 12/7, with the 30/6.5 362 
formulation being close to the 100% VO diet in the present study (Torstensen et al., 363 
2008). In this study, SGR values were in the range 0.42-1.06 and FCRs in the range 364 
0.77-0.91. These are similar to the present study with the SGRs being slightly lower, 365 
probably due to lower water temperatures, and the FCRs being slightly better due to 366 
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the earlier trial being a tank trial where feed delivery and consumption can be more 367 
closely monitored compared to cage culture. However, the VO diet used in the 368 
present study had much lower levels of DHA and EPA (1.5 and 1.2% of total fatty 369 
acids) compared to the diets used by Torstensen et al. (2008) that had only 70% FO 370 
replacement, and percentages of DHA and EPA of 3.0 and 2.5, respectively. This 371 
50% reduction in dietary n-3 LC-PUFA resulted in no apparent reduction in growth 372 
compared to the salmon produced by Torstensen et al. (2008).  373 
The current study is the first to consider growth parameters and flesh fatty acids in 374 
market-size Atlantic salmon from different genetic backgrounds and different 375 
potentials for lipid accumulation and metabolism. Significant differences in fish final 376 
weight were attributable to fish group and there was also an interaction between 377 
group and diet. The largest fish were the Fat and Lean fish fed FO and this might be 378 
due in part to these fish being larger than the CAL fish at the start of the trial. 379 
However, while the Lean and Fat groups fed VO had lower growth than the same 380 
fish fed FO this was not the case for the CAL fish suggesting that the CAL strain 381 
may have performed more effectively with the high VO diet. Although no 382 
comparable studies on different genetic groups have been reported in Atlantic 383 
salmon, some studies have considered strain differences in coho salmon, rainbow 384 
trout and other species. In a study where rainbow trout had been selected on carcass 385 
adiposity using a non-invasive fat meter, as was also done in the present study, the 386 
strains (Fat, control and Lean) were all different from each other, based on muscle 387 
lipid content analysed by Soxhlet, in the order Fat > control > Lean (Quillet et al., 388 
2005). No details of diet were provided except that it was commercial diet containing 389 
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22% lipid, which would likely contain predominantly FO. In the present trial, 390 
differentiation was achieved by a single round of selection. By contrast to the trout 391 
strains, the salmon groups showed differences in % VSI and HSI related to both fish 392 
group and diet x group interaction (Quillet et al., 2005).  393 
Another study compared growth and fatty acid compositions in two strains of 394 
Atlantic salmon parr (landlocked or anadromous) fed 5 different diets varying in 395 
relative ratios of olive, sunflower and linseed oils, for 8 weeks (Rollin et al., 2003). 396 
They found that growth rate was higher in the landlocked strain but there was no 397 
effect due to the different diets, and the impact of the different diets had a more 398 
pronounced effect on carcass fatty acid compositions than that of the different strains 399 
(Rollin et al., 2003). In the present study, virtually all flesh fatty acids were 400 
significantly affected by diet, which is expected, and was seen in similar studies with 401 
salmon fed high levels of VO (Torstensen et al., 2000, 2005; Bell et al., 2003, 2004; 402 
Tocher et al., 2003). The saturated fatty acids 16:0, 18:0 and total saturates were 403 
significantly affected by both fish group and diet with the CAL fish having higher 404 
flesh saturates than the Lean and Fat groups, with lowest levels in the Lean fish. 405 
Generally this was balanced by the Lean fish having higher n-3 LC-PUFA levels and 406 
this would be expected if the Lean fish were lower in total lipid, compared to the 407 
other groups, as these fish should contain more polar lipid and less neutral lipid in 408 
their flesh stores. Flesh with less neutral and more polar lipid would tend to 409 
accumulate more LC-PUFA and less saturates than the opposite situation seen, for 410 
example in the Fat FO fish (Sargent et al., 2002). The above effect was not seen in 411 
the VO-fed fish as the lipid deposition pattern was altered in the fish fed VO 412 
 19 
compared to FO. The absence of increased LC-PUFA in the lean VO fish may also 413 
have been influenced by the higher 18:2n-6 content in these fish. It is known that 414 
18:2n-6 can compete with LC-PUFA for the sn-2 position on phospholipids thereby 415 
preventing any increase in LC-PUFA in the phospholiopid fraction. Another 416 
potential impact on flesh fatty acids could be the relative activities of the biosynthetic 417 
pathways that generate LC-PUFA from their C18 precursors and this has been 418 
investigated previously to include both diet and strain effects (Tocher et al., 2001, 419 
2003; Rollin et al., 2003). A number of other studies have observed differences in 420 
metabolism, deposition and retention of LC-PUFA in different salmon strains and 421 
there is evidence that this is influenced both by genetic as well as environmental 422 
effects (Pickova et al., 1999; Peng et al., 2003). While no direct measure of fatty acid 423 
metabolism was conducted in the present study, microarray analysis of the liver 424 
transcriptome was analysed to assess effects on global gene expression and this will 425 
be presented separately. 426 
Many studies have now been conducted on FO replacement in salmon and the 427 
influence of VO in reducing the flesh levels of LC-PUFA is a well-known effect of 428 
such replacement (Torstensen et al., 2000, 2004a,b, 2005, 2008; Rosenlund et al., 429 
2001; Bell et al., 2002, 2003, 2004; Grisdale-Helland et al., 2002; Bransden et al., 430 
2003). Salmon is a species with oily flesh that can deliver significant levels of n-3 431 
LC-PUFA to consumers and it is important to maintain a positive image for the 432 
species in this respect as the health benefits of increased dietary n-3 LC-PUFA intake 433 
in humans are well documented (Ruxton et al., 2005; Hibbeln and Davis, 2009; Park 434 
et al., 2009). One way to successfully restore n-3 LC-PUFA is to dilute or wash out 435 
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the VO-derived fatty acids using a FO finishing diet (Bell et al., 2004; 2005; 436 
Torstensen et al., 2004a, 2005) but this has not previously involved different fish 437 
genetic groups, that have differences in flesh lipid deposition that may affect the time 438 
and efficacy of the wash out process. 439 
At 55 weeks sampling there were no differences in % DHA + EPA between the 440 
three groups previously fed VO. However, after 16 weeks of the wash-out process 441 
the Lean fish fed VO had significantly higher levels of DHA + EPA compared to the 442 
Fat and CAL fish previously fed VO. This suggests that the Lean strain were able to 443 
accumulate n-3 LC-PUFA more rapidly than the other two strains, although after 24 444 
weeks this difference was abolished. However, this study suggests that LC-PUFA 445 
uptake and deposition may be under genetic control and could be exploited to 446 
maintain or restore LC-PUFA, following a period of dietary restriction, by selecting 447 
for this trait. 448 
There is currently interest in increasing fish intake, especially oily fish, as a way 449 
of increasing n-3 LC-PUFA levels in populations with traditionally low fish 450 
consumption rates. The current advice from ISSFAL is to consume at least 500mg of 451 
DHA + EPA/day or 3.5g/week to provide good cardiovascular health in adult 452 
humans (ISSFAL, 2004). Consuming a 140g portion of salmon from the present trial, 453 
following the 16 week finishing diet period, would provide between 1.62 – 2.67g 454 
DHA + EPA (CAL VO and Fat FO, respectively) and, after 24 weeks on the 455 
finishing diet, these values increased to 2.21-2.90g/140g portion (Fat VO and CAL 456 
FO, respectively). The current guideline of the UK Food Standards Agency 457 
(www.food.gov.uk) suggests we should consume two to four 140g portions of oily 458 
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fish/week. Consuming two x 140g portions of salmon produced in the current trial, 459 
after a 16 week finishing diet period, would easily exceed the ISSFAL recommended 460 
weekly intake for DHA + EPA of 3.5g.  461 
 462 
5. Conclusions 463 
This study has demonstrated that Atlantic salmon can be cultured using diets with 464 
reduced FM and complete replacement of FO, over the seawater production phase, 465 
without any detriment to growth and feed conversion. Fish fed the VO diets had n-3 466 
LC-PUFA levels reduced by ~65% compared to fish fed FO although this could be 467 
effectively restored by a 16 week FO finishing diet phase. A novel aspect of this 468 
study was the use of fish from different genetic backgrounds to investigate 469 
differences in growth and fatty acid deposition/retention. Differences were seen 470 
between groups due to diet as well as interactions between fish group and diet. The 471 
differences observed suggested that genetic background had an influence on lipid 472 
deposition and metabolism and that selective breeding programmes could be used to 473 
select salmon families that retained more n-3 LC-PUFA in their flesh, particularly 474 
when fed diets low in these fatty acids.  475 
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Figure legends 663 
Fig. 1. Flesh total lipid 22:6n-3 + 20:5n-3 concentrations (weight % of total fatty acids) 664 
in the three salmon strains and two dietary treatments at final sampling and after 16 and 665 
24 weeks on a 100% FO finishing diet. Error bars represent mean ± SD. Columns 666 
assigned a different letter, within each time point, are significantly different (P < 0.05). 667 
 668 
Fig. 2. The concentration of flesh 22:6n-3 + 20:5n-3 (g/140g) in the three salmon strains 669 
and two dietary treatments at final sample and after 16 and 24 weeks on a FO finishing 670 
diet. The dotted line represents the weekly intake values for DHA + EPA for humans 671 
recommended by the International Society for the Study of Fatty Acids and Lipids 672 
(ISSFAL). 673 
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